AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

Vita Life Sciences Ltd: Annual Report to shareholders

ASXMar 24 01:29 ET · Announcements

Vita Life Sciences Announces Cessation of Securities in Strategic Buy-Back

TipRanksMar 10 21:29 ET

Vita Life Sciences Ltd To Go Ex-Dividend On March 21st, 2025 With 0.065 AUD Dividend Per Share

Moomoo NewsFeb 24 15:35 ET

Vita Life Sciences Ltd: Preliminary Final Report

ASXFeb 23 16:12 ET · Announcements

Vita Life Sciences Buys Back Nearly 18,000 Shares

MT NewswiresJan 10 01:34 ET